Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.51 |
| ▸ | PGR | P06401 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.43 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | RXRA | P19793 | 2/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11867182 | 0.86 | CYP4F2 (0.50) | CYP4F2CYP4A11ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL11867176 | 0.86 | CYP4F2 (0.50) | CYP4F2CYP4A11ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL441962 | 0.83 | ADORA3 (0.46) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL2879705 | 0.82 | ADORA3 (0.53) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL11319629 | 0.79 | ADORA3 (0.38) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL17307880 | 0.77 | ADORA3 (0.59) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL28728348 | 0.76 | CYP4F2 (0.51) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL13491238 | 0.76 | ALDH1A1 (0.58) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL17307884 | 0.75 | ALDH1A1 (0.57) | ADORA3NR1I2PTGS2PGRPDE4D | |
| SCHEMBL17307883 | 0.74 | ALDH1A1 (0.60) | ADORA3NR1I2PTGS2PGRPDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166228-A1 | COMPOSITION | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-07-07 | — | — | US | disclosed |
| EP-2102139-A2 | OMEGA-3 LIPID COMPOUNDS | Pronova Biopharma Norge AS (NO) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008142482-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166228-A1 | COMPOSITION | ELOVL3, FFAR3, ALOX5 | ADORA3 209/4885NR1I2 597/4885PTGS2 640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.